1343P Adding Histology-Driven Chemotherapy (cht) to Overcome Primary Resistance to First-Line Immunotherapy (ICI) in Patients (pts) with Advanced Non-Small Cell Lung Cancer (ansclc) with PD-L1 ≥50%
Annals of Oncology（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined